Oregon Public Employees Retirement Fund Blueprint Medicines Corp Transaction History

Oregon Public Employees Retirement Fund

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 20, 2020	SELL	$48.11 - $82.22 $120,275 - $205,550	-2,500 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$66.73 - $82.59 $166,825 - $206,475	-2,500 Reduced 50.0%	2,500 $200,000
Q3 2019 Nov 07, 2019	SELL	$72.9 - $101.41 $364,500 - $507,050	-5,000 Reduced 50.0%	5,000 $367,000
Q2 2019 Jul 16, 2019	BUY	$73.54 - $97.8 $735,400 - $978,000	10,000 New	10,000 $943,000

352

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $5.65B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Oregon Public Employees Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on Oregon Public Employees Retirement Fund with notifications on news.